Novajen Daru

Novajen is an Iranian biopharmaceutical company and a prominent member of the CinnaGen Pharmaceutical Group. The company specializes in the development, production, and marketing of high-tech biosimilars and recombinant proteins, focusing on therapeutic areas such as oncology, hematology, and musculoskeletal disorders. Its commercial portfolio includes key products like Neugen (filgrastim), Padynex (pegfilgrastim), and Bonajen (teriparatide). Novajen plays a significant role in the Middle East and North Africa (MENA) region's biotech landscape by providing cost-effective alternatives to expensive biological therapies. The company leverages advanced manufacturing standards and the R&D infrastructure of the CinnaGen Group to ensure the quality and efficacy of its life-saving medications.